Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Smoldering Multiple Myeloma 1Renal Insufficiency 1Bone Diseases 1

Interventions

Zoledronic Acid 4Denosumab 3Vitamin D 2saracatinib 1radium Ra 223 dichloride 1odanacatib 1etelcalcetide hydrochloride 1cabozantinib 1Standard of Care 1Progestins 1Pamidronate 1Paclitaxel 1Hormone Replacement Therapy 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bone Diseases × BHQ880 × Clear all
NCT00741377 2013-02-18

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Novartis

Phase 1 Completed
28 enrolled
Plasma cell

Bone Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡